Issued Patents All Time
Showing 1–25 of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12364750 | Conserved region T cell vaccines for coronavirus and methods of use | Bette T. Korber, James Theiler, Drew Weissman, Tomas Hanke | 2025-07-22 |
| 12312382 | Recombinant adenoviruses and uses thereof | Peter Abbink, Mark Justin Iampietro, Menzo Havenga | 2025-05-27 |
| 12023376 | Conserved region T cell vaccines for coronavirus and methods of use | Bette T. Korber, James Theiler, Drew Weissman, Tomas Hanke | 2024-07-02 |
| 11884718 | Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination | Shelly Krebs, Gina Donofrio, Vincent Dussupt, Kayvon Modjarrad, Richard G. Jarman, III +4 more | 2024-01-30 |
| 11845788 | Antibody therapies for human immunodeficiency virus (HIV) | Bruce A. Kerwin, Randal R. Ketchem, Alison J. Gillespie, Christine C. Siska, Rutilio Clark +3 more | 2023-12-19 |
| 11773142 | Recombinant adenoviruses and uses thereof | Peter Abbink, Mark Justin Iampietro, Menzo Havenga | 2023-10-03 |
| 11498944 | Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines | Johannes Petrus Maria Langedijk, Lucy Rutten, Mark Johannes Gerardus BAKKERS, Rinke Bos, Frank Wegmann +4 more | 2022-11-15 |
| 11384122 | Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines | Johannes Petrus Maria Langedijk, Lucy Rutten, Mark Johannes Gerardus BAKKERS, Rinke Bos, Frank Wegmann +4 more | 2022-07-12 |
| 11331386 | Antiviral vaccines with improved cellular immunogenicity | Bette T. Korber, William M. Fischer | 2022-05-17 |
| 11230572 | Signature-based human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the same | Christine BRICAULT, Bette T. Korber, Karina Yusim | 2022-01-25 |
| 11229696 | Biochemically stabilized HIV-1 Env trimer vaccine | Stephen C. Harrison, Bing Chen, Joseph P. Nkolola, Michael Scott Seaman | 2022-01-25 |
| 11207400 | Compositions and methods for inducing protective immunity against human immunodeficiency virus infection | Johanna SCHUITEMAKER, Maria Grazia Pau, Danielle VAN MANEN, Frank TOMAKA, Jennifer Anne HENDRIKS | 2021-12-28 |
| 11202830 | Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies in subjects with low viral loads | — | 2021-12-21 |
| 11059863 | Stabilized human immunodeficiency virus (HIV) envelope (ENV) trimer vaccines and methods of using same | Joseph P. Nkolola | 2021-07-13 |
| 10864263 | Method of providing safe administration of adenoviral vectors encoding a zika virus antigen | Macaya Julie DOUOGUIH, Gaston Rafael Picchio | 2020-12-15 |
| 10781427 | Recombinant adenoviruses and use thereof | Herbert W. Virgin, Peter Abbink | 2020-09-22 |
| 10772952 | Antiviral vaccines with improved cellular immunogenicity | Bette T. Korber, William M. Fischer | 2020-09-15 |
| 10716845 | Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using same | Christine BRICAULT | 2020-07-21 |
| 10653770 | Biochemically stabilized HIV-1 Env trimer vaccine | Stephen C. Harrison, Bing Chen, Joseph P. Nkolola, Michael Scott Seaman | 2020-05-19 |
| 10611801 | Compositions and methods for preventing and treating Zika virus infection | Peter Abbink, Rafael Larocca | 2020-04-07 |
| 10525123 | Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment | Frank TOMAKA, Maria Grazia Pau, Johanna SCHUITEMAKER, Jintanat Ananworanich, Merlin Robb +2 more | 2020-01-07 |
| 10471137 | Methods for inducing protective immunity against human immunodeficiency virus infection | Johanna SCHUITEMAKER, Maria Grazia Pau, Danielle VAN MANEN, Frank TOMAKA, Jennifer Anne HENDRIKS | 2019-11-12 |
| 10463729 | Biochemically stabilized HIV-1 env trimer vaccine | Stephen C. Harrison, Bing Chen, Joseph P. Nkolola, Michael Scott Seaman | 2019-11-05 |
| 10426831 | Antiviral vaccines with improved cellular immunogenicity | Bette T. Korber, William M. Fischer | 2019-10-01 |
| 10376583 | Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies and a reservoir activator | — | 2019-08-13 |